Pine Grove Financial Group
ABBV icon

Pine Grove Financial Group’s AbbVie ABBV Stock Holding History

Pine Grove Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$547K Buy
2,092
+156
+8% +$40K 0.05% 134
2026
Q2 		$482K Sell
1,936
-216
-10% -$46.5K 0.05% 133
2026
Q1 		$468K Sell
2,152
-14
-0.6% -$3.11K 0.05% 122
2025
Q4 		$495K Buy
+2,166
New +$493K 0.06% 115

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Pine Grove Financial Group's ABBV Position: Q3 2026 in Review

Pine Grove Financial Group increased its AbbVie (ABBV) stake by 8.1% in Q3 2026, buying an estimated $40K and bringing the position to 2,092 shares worth $547K. The position accounts for 0.05% of the portfolio, ranked #134.

Pine Grove Financial Group first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 2,873 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Pine Grove Financial Group held 2,092 shares of AbbVie worth $547K as of Q3 2026.
  • Pine Grove Financial Group bought 156 AbbVie shares in Q3 2026, an estimated $40K.
  • AbbVie made up 0.05% of Pine Grove Financial Group's portfolio in Q3 2026, its #134 holding.
  • Pine Grove Financial Group first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 2,873 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Pine Grove Financial Group's 13F filing for Q3 2026, filed 13 Oct 2026.